BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21038860)

  • 41. Integrin structures and conformational signaling.
    Luo BH; Springer TA
    Curr Opin Cell Biol; 2006 Oct; 18(5):579-86. PubMed ID: 16904883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of CD11b/CD18 adhesive activity by its extracellular, membrane-proximal regions.
    Xiong YM; Chen J; Zhang L
    J Immunol; 2003 Jul; 171(2):1042-50. PubMed ID: 12847278
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for hetero-association of transmembrane helices of integrins.
    Gottschalk KE; Kessler H
    FEBS Lett; 2004 Jan; 557(1-3):253-8. PubMed ID: 14741377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atypical structure and function of integrin α
    Song G; Luo BH
    J Cell Physiol; 2021 Jul; 236(7):4874-4887. PubMed ID: 33368230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interface between the EGF1 and EGF2 domains is critical in integrin affinity regulation.
    Hu P; Luo BH
    J Cell Biochem; 2018 Sep; 119(9):7264-7273. PubMed ID: 29797596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The relative influence of metal ion binding sites in the I-like domain and the interface with the hybrid domain on rolling and firm adhesion by integrin alpha4beta7.
    Chen J; Takagi J; Xie C; Xiao T; Luo BH; Springer TA
    J Biol Chem; 2004 Dec; 279(53):55556-61. PubMed ID: 15448154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanically Regulated Outside-In Activation of an I-Domain-Containing Integrin.
    Mao D; Lü S; Zhang X; Long M
    Biophys J; 2020 Sep; 119(5):966-977. PubMed ID: 32814058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alpha v beta 5 integrin-dependent programmed cell death triggered by a peptide mimic of annexin V.
    Cardó-Vila M; Arap W; Pasqualini R
    Mol Cell; 2003 May; 11(5):1151-62. PubMed ID: 12769841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrin bidirectional signaling: a molecular view.
    Qin J; Vinogradova O; Plow EF
    PLoS Biol; 2004 Jun; 2(6):e169. PubMed ID: 15208721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Why integrin as a primary target for imaging and therapy.
    Niu G; Chen X
    Theranostics; 2011; 1():30-47. PubMed ID: 21544229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrin structure: new twists and turns in dynamic cell adhesion.
    Arnaout MA
    Immunol Rev; 2002 Aug; 186():125-40. PubMed ID: 12234368
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Small molecule integrin antagonists that bind to the beta2 subunit I-like domain and activate signals in one direction and block them in the other.
    Shimaoka M; Salas A; Yang W; Weitz-Schmidt G; Springer TA
    Immunity; 2003 Sep; 19(3):391-402. PubMed ID: 14499114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transmembrane signal transduction of the alpha(IIb)beta(3) integrin.
    Gottschalk KE; Adams PD; Brunger AT; Kessler H
    Protein Sci; 2002 Jul; 11(7):1800-12. PubMed ID: 12070332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insights into integrin-ligand binding and activation from the first crystal structure.
    Humphries MJ
    Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S69-78. PubMed ID: 12110125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural specializations of α(4)β(7), an integrin that mediates rolling adhesion.
    Yu Y; Zhu J; Mi LZ; Walz T; Sun H; Chen J; Springer TA
    J Cell Biol; 2012 Jan; 196(1):131-46. PubMed ID: 22232704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrin receptor signaling: the propagation of an alpha-helix model.
    Marcantonio EE; David FS
    Matrix Biol; 1997 Oct; 16(4):179-84. PubMed ID: 9402007
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Integrin structure, activation, and interactions.
    Campbell ID; Humphries MJ
    Cold Spring Harb Perspect Biol; 2011 Mar; 3(3):. PubMed ID: 21421922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure of an integrin with an alphaI domain, complement receptor type 4.
    Xie C; Zhu J; Chen X; Mi L; Nishida N; Springer TA
    EMBO J; 2010 Feb; 29(3):666-79. PubMed ID: 20033057
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New insights into the structural basis of integrin activation.
    Xiong JP; Stehle T; Goodman SL; Arnaout MA
    Blood; 2003 Aug; 102(4):1155-9. PubMed ID: 12714499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrin structure: heady advances in ligand binding, but activation still makes the knees wobble.
    Humphries MJ; McEwan PA; Barton SJ; Buckley PA; Bella J; Mould AP
    Trends Biochem Sci; 2003 Jun; 28(6):313-20. PubMed ID: 12826403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.